CD73

CD73

a glycosylphosphatidylinositol-anchored membrane protein present on some B cells, some T cells, thymocytes, some epithelial and endothelial cells, and dendritic cells; expressed on most B-cell acute lymphoblastic leukemias, breast carcinomas, and large granular leukocyte leukemias.
References in periodicals archive ?
These cells expressed CD90, CD44, CD105, and CD73 but not CD45, CD11b, CD19, HLA-DR, and CD34 [Figure 2]b.
They found what they were looking for in the so-called CD73 gene.
After 3 passages the mesenchymal entity of BMMSCs was proved with special markers (expression of CD44 and CD73 and non-expression of CD45 and CD11b) using flow cytometry and their multi-potential entity was proved by their differentiation into osteogenic and adipogenic cells within 21 days (Soleimani & Nadri, 2009).
Third-passage DFSCs were incubated with the antibodies of positive markers for MSCs of human CD29 allophycocyanin (APC), CD73 phycoerythrin (PE), CD105 PE, and CD146 fluorescein isothiocyanate (FITC) and with the antibodies of negative markers of CD14 PE, CD34 FITC, CD45 APC, and HLA-DR PE (BD Biosciences, USA) for 15 min at room temperature in the dark.
The immunophenotypic profile was analyzed using the antibodies CD14, CD34, CD44, CD45, CD73, CD90, CD146, CD184, Stro-1 and HLA-DR (Becton Dickinson, USA) conjugated with FITC or PE fluorochrome.
Furthermore, inhalational anesthetics produce and promote anti-inflammatory mediators important for renal protection, including TGF-[beta]1 release, CD73 activation, and adenosine generation (20-22).
High concentration of adenosine in human visceral leishmaniasis despite increased ADA and decreased CD73.
The proinflammatory signaling of extracellular ATP is terminated by nucleotidases active in the interstitial fluid and the membrane-bound ectonucleotidases, CD39 and CD73 (Fig.
The criteria of the Mesenchymal and Tissue Stem Cell Committee of the International Society for Cellular Therapy reported that stem cells that expressing the markers of CD44, CD90, CD73 and CD105 are considered mesenchymal and those that express markers of CD19, CD14, CD34 or CD45 are regarded hematopoietic stem cells.
Hawrylowicz, "1[alpha],25-dihydroxyvitamin D3 acts via transforming growth factor-[beta] to up-regulate expression of immunosuppressive CD73 on human [CD4.